Posevaia T A, Kulcsar G, Horváth I, Dan P, Nasz I
Vopr Virusol. 1984 Nov-Dec;29(6):727-30.
The possibility of detecting virus-specific antigens in women with various pathological changes of the genitalia (cancer and pre-cancer conditions) was demonstrated. Comparative examinations of specimens from patients with cancer diseases of the genitalia for the presence of structural and virus-induced early antigens of HSV-2 demonstrated immunofluorescence test (IFT) to be the diagnostic test for the detection of HSV antigens in patients with cervical carcinoma. The rate of virus-induced antigen findings in the group of patients with cervical carcinoma was 51.6%, in precancer conditions, 31.7%, in recurrent genital herpes, 78.5%, in the control group of healthy women, 5%, by the IFT. The detection of virus-specific adenovirus and herpes antigens in human tumors is of interest for further investigation of a possible role of these viruses in the generation of malignant neoplasias and for the development of methods for specific immunodiagnosis.
已证实了在患有各种生殖器病理变化(癌症和癌前病变)的女性中检测病毒特异性抗原的可能性。对患有生殖器癌症疾病患者的标本进行比较检查,以检测单纯疱疹病毒2型(HSV-2)的结构和病毒诱导的早期抗原,结果表明免疫荧光试验(IFT)是检测宫颈癌患者中HSV抗原的诊断试验。通过IFT检测,宫颈癌患者组中病毒诱导抗原的发现率为51.6%,癌前病变患者组为31.7%,复发性生殖器疱疹患者组为78.5%,健康女性对照组为5%。在人类肿瘤中检测病毒特异性腺病毒和疱疹抗原,对于进一步研究这些病毒在恶性肿瘤发生中的可能作用以及开发特异性免疫诊断方法具有重要意义。